Castle Biosciences (CSTL) stock forecast for 2023

The forecast has been updated: September 23, 2022 9:16


Castle Biosciences stock price online today

Analyst Target Price

50.57

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell Castle Biosciences stock stock today? What is the projected target price level for 2023? How much will it cost in 2023? Castle Biosciences stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2023.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $50.57 target price for Castle Biosciences stock stock.

Today 200 Day Moving Average is the resistance level (32.08 $).

50 Day Moving Average is the resistance level (28.94 $).




CSTL Forecast for 2023

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 23.34 21.25 25.14 15.47 %
Feb 23.34 22.43 25.66 12.61 %
Mar 23.18 22.04 24.41 9.70 %
Apr 24.71 23.94 26.37 9.18 %
May 25.81 24.48 28.67 14.62 %
Jun 26.21 25.04 26.94 7.08 %
Jul 27.46 26.30 30.03 12.42 %
Aug 24.81 22.96 25.71 10.67 %
Sep 25.60 23.45 27.61 15.06 %
Oct 25.07 24.08 26.22 8.16 %
Nov 28.26 26.52 30.32 12.53 %
Dec 26.40 25.03 27.92 10.33 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of Castle Biosciences stock.


Castle Biosciences overview

Castle Biosciences Address

820 S FRIENDSWOOD DRIVE, SUITE 201, FRIENDSWOOD, TX, US

Market Capitalization

697 922 000 $

EBITDA

-67 947 000

PE Ratio

None

PEG Ratio

None

Dividend Per Share

0

Dividend Yield

0

EPS

-2.044

Quarterly Earnings Growth YOY

-0.926

Quarterly Revenue Growth YOY

0.531

Trailing PE

-

Forward PE

-

EV To Revenue

4.07

EV To EBITDA

-9.4

52 Week High

74.64

52 Week Low

15.58

50 Day Moving Average

28.94

200 Day Moving Average

32.08

Shares Outstanding

26297000

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

Castle Biosciences stock forecast for this year


Castle Biosciences stock forecast for Jan 2023.
Estimated Average Forecasted Castle Biosciences Price: 23.34. Negative monthly dynamics of the instrument is expected with 15.469% volatility is expected.

Pessimistic forecast: 21.25

Optimistic: 25.14


Castle Biosciences stock forecast for Feb 2023.
Estimated Average Forecasted Castle Biosciences Price: 23.34. Negative monthly dynamics of the instrument is expected with 12.607% volatility is expected.

Pessimistic forecast: 22.43

Optimistic: 25.66


Castle Biosciences stock forecast for Mar 2023.
Estimated Average Forecasted Castle Biosciences Price: 23.18. Negative monthly dynamics of the instrument is expected with 9.704% volatility is expected.

Pessimistic forecast: 22.04

Optimistic: 24.41


Castle Biosciences stock forecast for Apr 2023.
Estimated Average Forecasted Castle Biosciences Price: 24.71. Positive monthly dynamics of the instrument is expected with 9.183% volatility is expected.

Pessimistic forecast: 23.94

Optimistic: 26.37


Castle Biosciences stock forecast for May 2023.
Estimated Average Forecasted Castle Biosciences Price: 25.81. Positive monthly dynamics of the instrument is expected with 14.623% volatility is expected.

Pessimistic forecast: 24.48

Optimistic: 28.67


Castle Biosciences stock forecast for Jun 2023.
Estimated Average Forecasted Castle Biosciences Price: 26.21. Positive monthly dynamics of the instrument is expected with 7.081% volatility is expected.

Pessimistic forecast: 25.04

Optimistic: 26.94


Castle Biosciences stock forecast for Jul 2023.
Estimated Average Forecasted Castle Biosciences Price: 27.46. Positive monthly dynamics of the instrument is expected with 12.415% volatility is expected.

Pessimistic forecast: 26.30

Optimistic: 30.03


Castle Biosciences stock forecast for Aug 2023.
Estimated Average Forecasted Castle Biosciences Price: 24.81. Negative monthly dynamics of the instrument is expected with 10.672% volatility is expected.

Pessimistic forecast: 22.96

Optimistic: 25.71


Castle Biosciences stock forecast for Sep 2023.
Estimated Average Forecasted Castle Biosciences Price: 25.60. Positive monthly dynamics of the instrument is expected with 15.059% volatility is expected.

Pessimistic forecast: 23.45

Optimistic: 27.61


Castle Biosciences stock forecast for Oct 2023.
Estimated Average Forecasted Castle Biosciences Price: 25.07. Negative monthly dynamics of the instrument is expected with 8.163% volatility is expected.

Pessimistic forecast: 24.08

Optimistic: 26.22


Castle Biosciences stock forecast for Nov 2023.
Estimated Average Forecasted Castle Biosciences Price: 28.26. Positive monthly dynamics of the instrument is expected with 12.528% volatility is expected.

Pessimistic forecast: 26.52

Optimistic: 30.32


Castle Biosciences stock forecast for Dec 2023.
Estimated Average Forecasted Castle Biosciences Price: 26.40. Negative monthly dynamics of the instrument is expected with 10.327% volatility is expected.

Pessimistic forecast: 25.03

Optimistic: 27.92



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 100.68 (23.09.2022) -0.39 %
AbbVie Inc.
ABBV 143.06 (23.09.2022) 0.03 %
Aeterna Zentaris Inc.
AEZS 3.98 (23.09.2022) -3.40 %
Allakos Inc.
ALLK 5.25 (23.09.2022) -0.94 %
Allogene Therapeutics, Inc.
ALLO 10.62 (23.09.2022) -2.03 %
Amgen Inc.
AMGN 226.97 (23.09.2022) -0.34 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 3.31 (23.09.2022) -2.93 %
Aurora Cannabis Inc.
ACB 1.2 (23.09.2022) -1.64 %
Becton Dickinson and Company
BDX 233.92 (23.09.2022) -1.38 %
Biogen Inc.
BIIB 197.78 (23.09.2022) -1.42 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 151.15 (21.09.2022) -0.07 %
BioNTech SE
BNTX 128.35 (23.09.2022) -1.27 %
bluebird bio, Inc.
BLUE 5.62 (23.09.2022) -5.86 %
Boston Scientific Corp.
BSX 39.3 (22.09.2022) -1.16 %
Bristol-Myers Squibb Company
BMY 70.71 (23.09.2022) -0.81 %
Canopy Growth Corp.
CGC 2.84 (23.09.2022) 4.41 %
Castle Biosciences, Inc.
CSTL 24.65 (23.09.2022) -1.40 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 20.86 (23.09.2022) -1.32 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 12.43 (23.09.2022) -2.66 %
Gilead Sciences, Inc.
GILD 62.86 (23.09.2022) -1.43 %
GlaxoSmithKline plc
GSK 29.36 (23.09.2022) -2.17 %
GoodRx Holdings, Inc.
GDRX 5.15 (23.09.2022) -1.90 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 66.89 (23.09.2022) -0.77 %
Inovio Pharmaceuticals, Inc.
INO 1.71 (23.09.2022) -3.39 %
Johnson & Johnson
JNJ 166.72 (23.09.2022) 0.32 %
Medtronic plc.
MDT 82.66 (23.09.2022) -1.08 %
Merck & Co., Inc.
MRK 86.78 (23.09.2022) -0.83 %
Moderna, Inc.
MRNA 123.64 (23.09.2022) -0.55 %
Novartis AG
NVS 76.01 (23.09.2022) -1.46 %
Novavax, Inc.
NVAX 21 (23.09.2022) -6.42 %
ObsEva SA
OBSV 0.141 (23.09.2022) -4.08 %
OrganiGram Holdings Inc.
OGI 0.8914 (23.09.2022) -0.96 %
Pfizer Inc.
PFE 44.08 (23.09.2022) -1.10 %
Regeneron Pharmaceuticals, Inc.
REGN 697.33 (23.09.2022) 1.32 %
Sanofi
SNY 38.4 (23.09.2022) -1.87 %
Schrodinger, Inc.
SDGR 24.12 (23.09.2022) -3.44 %
Senseonics Holdings, Inc.
SENS 1.32 (23.09.2022) 3.13 %
Sorrento Therapeutics, Inc.
SRNE 1.55 (23.09.2022) -4.32 %
Stryker Corp.
SYK 206.93 (23.09.2022) -0.93 %
Sundial Growers Inc.
SNDL 2.3 (23.09.2022) -0.86 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 7.9 (23.09.2022) -1.99 %
Thermo Fisher Scientific Inc.
TMO 520.79 (23.09.2022) 0.10 %
Tilray, Inc.
TLRY 2.72 (23.09.2022) -2.86 %
UnitedHealth Group, Inc.
UNH 513.61 (23.09.2022) -0.74 %
Veeva Systems Inc.
VEEV 162.57 (23.09.2022) -0.19 %
Zomedica Corp.
ZOM 0.2091 (23.09.2022) -2.74 %
Zynerba Pharmaceuticals, Inc.
ZYNE 0.87 (23.09.2022) -6.60 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.